Skip to main content
. 2018 Apr 27;9(10):1863–1869. doi: 10.7150/jca.24950

Fig 2.

Fig 2

The duration of crizotinib treatment in 38 ALK/ROS1-positive patients. Brown bars indicate PFS1, blue bars indicate PFS2.